Type of security: Stock
Sector: Capital Goods
Market Capitalization: 4.03 B
The data is delayed by 15 minutes.
Description: Bruker Corporation, together with its subsidiaries, designs, manufactures, sells, and services proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy & Supercon Technologies. The Scientific Instruments segment offers instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. The Energy & Supercon Technologies segment
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||162.76 M||EPS||1.06||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-22.72%||Sales Growth - Q/Q||-30.41%||P/E||26.14|
|P/E To EPS Growth||P/S||2.32||P/BV||5.63||Price/Cash Per Share||8.19|
|Price/Free Cash Flow||50.06||ROA||3.07%||ROE||7.61%||ROI||4.44%|
|Current Ratio||2.41||Quick Ratio||1.54||Long Term Debt/Equity||0.46||Debt Ratio||0.76|
|Gross Margin||42.78%||Operating Margin||5.75%||Net Profit Margin||3.13%||Dividend Payout Ratio|
|Cash From Financing Activities||4.1 M||Cash From Investing Activities||-5.7 M||Cash From Operating Activities||27 M||Gross Profit||160.2 M|
|Net Profit||6.5 M||Operating Profit||15.2 M||Total Assets||1.77 B||Total Current Assets||1.3 B|
|Total Current Liabilities||540.5 M||Total Debt||354.6 M||Total Liabilities||1.06 B||Total Revenue||353.5 M|
|High 52 week||43.43||Low 52 week||26.45||Last close||41.33||Last change||-2.48%|
|RSI||62.07||Average true range||1.45||Beta||1.24||Volume||306.96 K|
|Simple moving average 20 days||2.21%||Simple moving average 50 days||5.07%||Simple moving average 200 days||18.35%|
|Performance Week||-3.66%||Performance Month||8.38%||Performance Quart||9.15%||Performance Half||26.74%|
|Performance Year||37.67%||Performance Year-to-date||38.83%||Volatility daily||2.96%||Volatility weekly||6.61%|
|Volatility monthly||13.55%||Volatility yearly||46.95%||Relative Volume||101.22%||Average Volume||733.26 K|
|New High||New Low|
2019-11-15 07:00:00 | Bruker Corporation to Present at Investor Conferences
2019-11-14 07:00:00 | Bruker Announces Quarterly Dividend
2019-11-10 15:48:51 | 3 Stocks to Enhance Your Portfolio's Quality
2019-11-05 03:36:18 | Edited Transcript of BRKR earnings conference call or presentation 31-Oct-19 8:30pm GMT
2019-11-02 08:07:39 | What Did Bruker Corporation's NASDAQ:BRKR CEO Take Home Last Year?
2019-11-01 09:50:01 | Bruker BRKR Beats Q3 Earnings Estimates, Ups EPS Guidance
2019-10-31 17:55:09 | Bruker BRKR Beats Q3 Earnings and Revenue Estimates
2019-10-31 16:05:00 | Bruker Reports Third Quarter 2019 Financial Results
2019-10-24 10:32:02 | Bruker BRKR Earnings Expected to Grow: Should You Buy?
2019-10-22 16:30:59 | Hedge Funds Have Never Been This Bullish On Bruker Corporation BRKR
2019-10-21 07:00:00 | Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast
2019-10-13 09:10:26 | Estimating The Intrinsic Value Of Bruker Corporation NASDAQ:BRKR
2019-10-07 06:36:10 | Bruker To Buy Freiberg Instruments' Magnettech EPR Business
2019-10-02 07:00:00 | Bruker Announces Acquisition of Magnettech's EPR Business
2019-09-25 10:29:24 | Here's Why Bruker NASDAQ:BRKR Can Manage Its Debt Responsibly
2019-09-23 09:44:01 | Bruker BRKR Enters Into Alliance With Murdoch University
2019-09-12 09:09:01 | Bruker BRKR Introduces the nanoIR3-s Broadband System
2019-09-09 18:15:08 | Bruker Corp BRKR Pres. & CEO, Bruker EST Burkhard Prause Sold $674,558 of Shares
2019-09-05 07:19:27 | Need To Know: Bruker Corporation NASDAQ:BRKR Insiders Have Been Selling Shares
2019-09-03 09:19:01 | Bruker BRKR Releases JPK NanoWizard 4 XP Bio-AFM System
2019-09-02 07:00:00 | Bruker Launches Highest Resolution Large-Format Bio-AFM System
2019-08-31 09:31:01 | Bruker BRKR Down 7.4% Since Last Earnings Report: Can It Rebound?
2019-08-26 07:00:00 | Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data
2019-08-18 09:39:25 | Does The Data Make Bruker Corporation NASDAQ:BRKR An Attractive Investment?
2019-08-12 07:00:00 | Bruker Announces Quarterly Dividend
2019-08-02 12:57:48 | Edited Transcript of BRKR earnings conference call or presentation 1-Aug-19 8:30pm GMT
2019-08-02 08:24:06 | Bruker BRKR Q2 2019 Earnings Call Transcript
2019-08-02 08:05:12 | Bruker BRKR Q2 Earnings Beat Estimates, Margins Expand
2019-08-01 18:25:10 | Bruker BRKR Beats Q2 Earnings and Revenue Estimates
2019-08-01 16:05:00 | Bruker Reports Second Quarter 2019 Financial Results
2019-07-31 10:40:02 | Garmin's GRMN Q2 Earnings & Revenues Surpass Estimates
2019-07-30 14:44:19 | At US$48.58, Is Bruker Corporation NASDAQ:BRKR Worth Looking At Closely?
2019-07-29 11:38:03 | Can Bruker BRKR Q2 Earnings See BioSpin's Growth Revival?
2019-07-29 09:30:01 | Is Bruker BRKR Outperforming Other Computer and Technology Stocks This Year?
2019-07-25 10:33:02 | Bruker BRKR Earnings Expected to Grow: Should You Buy?
2019-07-23 16:05:00 | Bruker Announces Date and Time of Second Quarter 2019 Earnings Release and Webcast
2019-07-17 07:00:00 | Bruker Comments on Block Trade Transaction
2019-07-11 11:10:03 | Illumina ILMN Grows on Innovation & International Growth
2019-07-11 07:19:11 | NuVasive NUVA Launches Pulse Integrated Technology Platform
2019-07-10 11:11:03 | Boston Scientific's Global Growth Robust Amid Currency Woe
2019-07-10 09:30:01 | Has Bruker BRKR Outpaced Other Computer and Technology Stocks This Year?
2019-07-10 08:22:12 | Medtronic Releases Positive Results of LATERAL Clinical Trial
2019-07-09 09:36:01 | ResMed RMD Rides on Strong SaaS Growth & New Product Suite
2019-07-09 09:30:01 | Integra Partners AI-Driven Data Analytics Firm in Wound Care
2019-07-09 08:18:12 | Phibro Animal Sees Crucial Progress in ASF Vaccine Development
2019-07-09 07:48:11 | Fresenius Set for Global Expansion of Research Activities